Hudson S et al
The primary antibodies employed were: P53 (Proteintech, 60283-2-Ig), pSer46-P53 (CST, 2521), FOXO4 (Proteintech, 21535-1-AP), P21 (CST, 2947), P16 (CST, 18769), BAX (CST, 2772), BCL2 (CST, 3498), Ki-67 (Proteintech, 84192-4-RR), Lamin B (CST, 13435), Cleaved Caspase 3 (CST, 9664), -H2AX (Abcam, ab81299), and GAPDH (Abcam, ab8245) as an internal reference for normalizing protein expression levels
While effective, this treatment is costly, not widely available, and can place significant stress on the liver and kidneys
Compared to traditional capsules and tablets, the gummy format better aligns with the preferences of young consumers for products that are "convenient, delicious, and easy to consume." In recent years, this product category has experienced rapid growth within the cross-border e-commerce market
and Nakaki, T